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Abstract. – OBJECTIVE: Synthetic cathinones, 
more commonly known as “bath salts”, are syn-
thetic drugs chemically related to cathinone, a 
psychostimulant found in the khat plant. They are 
the first most consumed products among new 
psychoactive substances, which cause psycho-
stimulant and hallucinogenic effects determining 
a number of fatalities worldwide. In this paper, we 
have systematically reviewed cases of synthet-
ic cathinones-related fatalities analytically con-
firmed, which have occurred in the last few years.
MATERIALS AND METHODS: Relevant scien-
tific articles were identified in Medline, Cochrane 
Central, Scopus, Web of Science and Institution-
al/government websites up to November 2017 
using the following keywords: synthetic cathi-
nones, mephedrone, methylenedioxypyrovale-
rone, MDPV, methylone, ethylone, buthylone, fa-
tal intoxication, fatalities and death.
RESULTS: In total, 20 citations met the criteria 
for inclusion, representing several fatal cases 
with analytically confirmed synthetic cathinones 
in biological sample/s of the deceased. The 
death was attributed to hyperthermia, hyperten-
sion, cardiac arrest and more in general to the 
classic serotonin syndrome. Only rarely did the 
concentration of the parent drug causing fatali-
ty overcome the value of 1 mg/L in post-mortem 
biological fluids. 
CONCLUSIONS: Abuse of synthetic cathi-
nones still represents a serious public health is-
sue. Systematic clinical studies on both the ani-
mal and human model are lacking; therefore, the 
only available data are from the users who expe-
rience the possible hazardous consequences. 
Analytical methodologies for the identification 
of parent compounds and eventual metabolites 
both in ante-mortem and post-mortem cases 
need to be developed and validated. Analytical 
data should be shared through different commu-
nication platforms with the aim of stopping this 
serious health threat for drug users.
Key Words: 
Synthetic cathinones, Fatalities, Serotonin syn-
drome, Bath salts.
Introduction
Synthetic cathinones, more commonly known 
as “bath salts”, are synthetic drugs chemically 
related to cathinone, a psychostimulant found in 
the khat plant. They are the first most consumed 
products among new psychoactive substances 
exerting psychostimulant and hallucinogenic 
effects, similar to those of cocaine, 3,4-methy-
lenedioxymethamphetamine (MDMA), amphet-
amines and methamphetamines1,2. Indeed, they 
are marketed as cheap substitutes for the latter 
compounds. Synthetic variants of cathinone can 
be much more potent than the natural product 
and, in some cases, very dangerous or even le-
thal3. A number of synthetic cathinones related 
deaths have been published1. Synthetic cathi-
nones, referred to as “bath salts”4, can be found 
in the form of a brown or white crystal-like pow-
der and are sold in small foil or plastic packages 
labeled as “not for human consumption”, “jewel-
ry cleaner”, “plant food” or “phone screen clean-
er”. They are available online and in drug para-
phernalia stores under a variety of brand names, 
such as Flakka, Cloud Nine, Lunar Wave, White 
Lightning, Bloom, Scarface and Vanilla Sky. In 
2013, European countries reported more than 
110 NPS products containing a combination of 
up to seven different NPS compounds sold as 
one product. Synthetic cannabinoids were found 
to be present in more than 55% of these NPS 
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products, and synthetic cathinones were present 
in more than 25%5.
In some countries, shortage of heroin and an in-
crease in local availability of synthetic cathinones 
contributed to high-risk drug users switching to 
injecting NPS, primarily synthetic cathinones, as 
reported by WDR 2016. New synthetic cathinones 
are continuously emerging; although data collec-
tion for 2015 is still in progress, 75 new substances 
have been reported to UNODC for the first time, 
among which 20 belong to synthetic cathinones 
group compared to 21 newly emerged synthetic 
cannabinoids. Moreover, global seizures of syn-
thetic cathinones have been steadily increasing 
since they were first reported in 2010. Those sei-
zures tripled between 2013 and 2014, reaching 1.3 
tons. Most synthetic cathinones were seized in Eu-
rope and in East and South-East Asia 5. The acute 
and chronic toxicity of many synthetic cathinones 
is unknown or very sparsely investigated. Informa-
tion of related fatalities has not been recently sys-
tematized. In this review, we aimed to report most 
recent analytically confirmed cases of synthetic 
cathinones-related fatalities.
Materials and Methods
Relevant scientific publications were identified 
from Pubmed, Cochrane Central, Scopus, Web of 
Science and Institutional/government websites up 
to November 2017 using the following keywords: 
synthetic cathinones, mephedrone, methylene-
dioxypyrovalerone, MDPV, methylone, ethylone, 
buthylone, fatal intoxication, fatalities and death. 
The first seven keywords were individually sear-
ched and then in association to each of the last 
three. Inclusion criteria were as follows: 1) arti-
cles had to be written in English; 2) described hu-
man administration of one or more synthetic ca-
thinones was required; 3) analytically confirmed 
the presence of one or more synthetic cathinones 
was required; 4) death had to be attributed to one 
or more synthetic cathinones either alone or in 
combination with other substances.
Results
After an initial screening, a total of 96 citations 
were identified, but only 20 met the inclusion cri-
teria. Ten different compounds were found as the 
cause of synthetic cathinones fatalities and their 
structural formula has been reported in Figure 1.
It has to be noted that in some cases the in-
gestion of a synthetic cathinone was not the di-
rect cause of death, but any event related to a 
psychotropic effect of the drug should be in any 
case taken into account. In briefly, in some be-
low-described cases, drug users died for different 
causes, the most frequent of them being suicides. 
Nevertheless, it can be hypothesized that on the 
one hand users could have consumed synthetic 
cathinones with the aim of committing suicides; 
on the other hand users committed suicides under 
the psychoactive effects of the drug(s).
Fatalities associated with the most renowned 
cathinone, mephedrone, have been recently re-
viewed by Busardò et al1 in 2015. Only 18 fatal ca-
ses were listed with analytically confirmed drug 
in post-mortem biological sample/s. The death 
was attributed to exclusive mephedrone intoxica-
tion in 9 cases (range of post-mortem blood me-
phedrone concentration: 1.33-22 mg/L), whereas 
mephedrone together with other drugs of abuse 
was reported as cause of death in 6 cases (range 
of post-mortem blood mephedrone concentration: 
0.04-1.3 mg/L). Similarly, in the same years co-
vered by the above-reported review, analysis of 
information come from the United Kingdom Na-
tional Programme on Substance Abuse Deaths 
disclosed 128 alleged mephedrone-associated fa-
talities6. However, only in 36 cases, mephedrone 
was identified in post-mortem biological samples 
and only in 10 cases mephedrone was identified as 
the only drug of abuse with mean concentrations 
of 1.43 mg/L (range = 0.03 – 22.0 mg/L) when it 
was presented with other drugs. A mean value of 
1.996 mg/L (range = <0.01 – 12.15 mg/L) when 
it was the sole drug. These figures excluded one 
combined mephedrone case with a level of > 2000 
mg/L. Death occurred mainly in weekends and 
typical victims were white males, with a previous 
history of drug abuse. 
In a description of a synthetic cathinones, re-
lated fatalities occurred in Miami (USA); in 2013 
methylenedioxypyrovalerone (MDPV) intoxica-
tion has been reported as a cause of death in a 
15 out of 23 cases. In 2 out of 4 hanging suicides, 
MDPV was the only significant drug found at a 
concentration of 0.10 and 0.64 mg/L peripheral 
blood. In all the other cases the presence of other 
psychoactive substances, mainly benzodiazepi-
nes, opioids and antidepressant drugs, was di-
sclosed with an average of 0.109 mg MDPV per L 
peripheral blood 7. 
In addition to this case series study, some 
MDPV-related fatalities have been described, all 
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with the common characteristics of hyperthermia 
and hypertension.
Firstly, in 2011 a raving man presented at the 
Emergency Room in a Baltimore hospital (MD, 
Figure 1. Molecular structures of synthetic cathinones involved in drug-related fatalities
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USA), in a delirium state. Once there, he deve-
loped ventricular tachycardia, hyperthermia, and 
died. Comprehensive drug testing showed heart 
blood with 0.7 mg/L MDPV and peripheral blood 
with 1.0 mg/L MDPV. The cause of death was de-
clared as MDPV fatal intoxication8.
Subsequently in 2012, in North Carolina 
(USA), a 40-year-old male who injected and 
snorted ‘‘bath salts’’ containing MDPV, became 
aggressive, uncontrollable and was admitted to 
the Emergency Department for bradycardia and 
subsequent cardiac arrest with MDPV present in 
his urine (0.670 mg/L) and serum (0.082 mg/L) 
analyzed at the time of admission. Later on, he 
developed hyperthermia, rhabdomyolysis, coa-
gulopathy, anemia, thrombocytopenia, acidosis, 
anoxic brain injury and finally died9. The same 
symptoms were explained in 2013 in USA for a 
20-year-old male and a 48-year-old female, both 
of whom presenting in addition a disseminated 
intravascular coagulation. The cathinone could 
be only detected in the ante-mortem blood of the 
male and measured in post-mortem blood of the 
female at a concentration of 29 mg/L10.
This latter extremely high MDVP concentra-
tion found in post-mortem blood represented an 
isolated case. Indeed, in all the others, the drug 
was lower than 1 mg per L biological fluid. This 
evidence, already enlightened in the previous ca-
ses, was also confirmed in a death occurred in 
2013 (Cleveland, OH, USA). A 39-year-old male 
died for a cardiac arrhythmia following the inge-
stion of MDPV. The drug was uniformly distribu-
ted among multiple tissues (blood, brain, muscle, 
cerebrospinal fluid and lung) at concentrations of 
approximately 0.4 to 0.6 mg/L. A femoral blood 
concentration 0.44 mg/L was judged sufficient to 
cause death11. 
As in the previous case of a firstly observed fa-
tality due to MDPV, a primarily case series of de-
aths due to methylone were reported in Baltimore 
(MD, USA) in 2012. Four post-mortem cases with 
suspicion of bath salts consumption were analy-
zed for cathinones, with drug levels quantitated 
in multiple biological matrices. All four cases 
showed detectable concentration of methylone, 
with heart blood concentrations of 0.740, 0.118, 
0.060 and 1.12 mg/L. Also, two cases had MDPV 
presented. In all cases, the cause of death was de-
fined as “accidental”12. 
Drowning due to acute methylone intoxication 
was diagnosed in a healthy 19-year-old woman 
with a history of recreational drug use found in 
2013 floating face down near the shore of a po-
pular beach in San Diego, (CA, USA). Methylone 
was detected as sole psychotropic drug in the pe-
ripheral blood, central blood, vitreous, liver and 
gastric contents of 3.4 mg/L 3.4 mg/L, 4.3 mg/L, 
11 mg/kg, and 1.7 mg, respectively13.
In the same 2013, once again in San Diego, 
a case of sudden death related to methylone 
(3,4-methylenedioxy-N-methylcathinonmethy-
lone) was evidenced in a healthy 19-year-old man, 
who consumed the drug, collapsed while jogging 
and died. Autopsy showed pulmonary congestion 
and edema, mild peribronchial inflammation, and 
mild hepatic portal and lobular inflammation.
Although the few reported fatalities due to meth-
ylone prevented a comparison of blood methylone 
concentrations between this case and existing re-
ports, the amount of post-mortem blood methylone 
(0.07 mg/dL or 0.7 mg/L) appeared to be below 
those reported in other drug-related fatalities14.
The fact that lethal concentrations of cathinones 
cannot be yet established, being available data very 
scarce, has been confirmed by two cases of cathi-
none-related deaths occurred in New York City 
area (NJ, USA). Indeed, conducing a 3-year ret-
rospective analysis of deaths in which cathinones 
were detected, two groups came out: 15 cases in 
which cathinones were a contributory cause of 
death together with many other ingested drugs of 
abuse and other 15 cases in which they were an 
incidental finding, but death causes were suicides, 
accidents, etc. In this case series, there were only 
two deaths attributed to acute cathinones intoxica-
tion, both with few hours’ survival after cathinone 
ingestion. One was a 20-year-old man who present-
ed to the Emergency Department unresponsive and 
with a body temperature of 41.6°C, after having 
consumed the drug at a rave party. He survived for 
10 h. His post-mortem heart blood methylone con-
centration was 0.71 mg/L. The other was a 25-year-
old woman found unresponsive in bed after a night 
party. At hospital she was resuscitated and sur-
vived 10 h more. Her post-mortem femoral blood 
ethylone concentration was 1.7 mg/L. In both case, 
cathinones concentration in post-mortem blood 
was not significantly higher than those in the other 
presented cases15. 
This case of ethylone fatality was not the only 
one. In 2015, nine post-mortem cases in whom 
ethylone was identified in blood, were evidenced 
in Gainesville, (FL, USA). In seven of the cases 
ethylone could be measured in blood, at a con-
centration from 0.038 to 2.572 mg/L; in one case 
ethylone was detected but not quantified and one 
case did not have detectable ethylone in blood. 
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a retrospective study of forensic autopsies, at the 
Department of Legal Medicine of Tokyo Women’s 
Medical University between January 2011 and Jan-
uary 2015. Among 359 autopsies, in only 3 cases, 
different synthetic cathinones were found as the 
cause of death and they were detected (even if con-
centration values were not reported) in post-mortem 
fluids. One fatal intoxication was due to 3’,4’-Meth-
ylenedioxy-α-pyrrolidinobutyrophenone (MDPBP), 
one to simultaneous ingestion of methylenedioxy-
pyrovalerone (MDPV), alphapyrrolidinovalerophe-
none (α-PVP), pyrovalerone and finally one due to 
4’-methyl-α-pyrrolidinohexiophenone (MPHP)21.
Apart from the above reported fatalities due to 
synthetic cathinones, most sold in the web sites 
and well known among users, there have been 
also some isolated fatalities due to less frequently 
used products.
In a Japanese study, which reviewed from 2012 
to 2014 poisonings due to synthetic cathinones 
and cannabinoids in six patients aged 22-42 years 
old, only one fatal case was pointed out, in which, 
a consumer of synthetic cannabinoids and cathi-
nones experienced cardiopulmonary arrest, acute 
circulatory failure and death after consumption of 
mepirapim (a synthetic cannabinoid) and α-ethyl-
aminopentiophenone (α-EAPP). Concentration of 
α-EAPP found in serum was 3.1 mg/L22.
1-phenyl-2-(1-pyrrolidinyl)-1-pentanone (α -PVP) 
caused cardiac arrest in a young man, admitted to 
the Intensive Care Unit of the Szczecin Hospital 
(Poland) in 2016. Laboratory analyses revealed 
the presence of α-PVP in the following concentra-
tions: blood 174 ng/mL, urine 401 ng/mL, brain 
292 ng/g, liver 190 ng/g, kidney 122 ng/g, gastric 
contents 606 ng/g23.
Finally, 3,4-dimethylmethcathinone (3,4-DMMC) 
was found in external iliac vein blood and urine 
at concentration of 27 mg/L and 7.6 mg/L, respec-
tively from a heroin user found dead by his par-
ents in his apartment with a post-mortem interval 
estimated to be approximately 1.5 days. Plastic 
packets of a product labeled as ‘‘LOOP 3’’ were 
found in the bedroom. These packets contained a 
fine white powder identified by forensic analyses 
as 3,4-DMMC, the synthetic cathinone found in 
post-mortem fluid of the deceased24.
Discussion
Although the presented results showed some 
case series of synthetic cathinones related fa-
talities, the evidence on deaths caused by these 
Besides ethylone, eight cases were also positive 
for 11-nor-9-carboxy-Δ9-tetrahydrocannabinol 
and seven cases to other drugs of abuse16.
In contrast with previous statement on the impos-
sibility to establish fatal cathinones concentrations, 
the County Medical Examiners of Tampa (FL, 
USA) in 2012 affirmed that peripheral blood methy-
lone concentrations more than 0.5 mg/L may result 
in death due to its toxic properties, being the main 
elevated body temperature and other sympathomi-
metic-like symptoms. This was the deduction com-
ing from three fatal intoxications cases following 
methylone consumption. In all three fatalities, the 
deceased exhibited seizure-like activity and body 
temperatures higher than 40°C before death. Pe-
ripheral blood methylone concentrations in the three 
fatal cases were 0.84, 3.3 and 0.56 mg/L17.
A case of a death following consumption of 
methylone in a party was also reported in France 
(Europe) in 2016. High concentrations of methy-
lone were found in the peripheral blood (3.13 mg/L) 
and in the central blood 6.64 mg/L of a 21-year-old 
man deceased for a respiratory distress. Drug pres-
ence in the gastric contents provided evidence that 
the substance was taken orally. The analysis of the 
peripheral blood and the urine showed an absence 
of any other drug of abuse or medication. The prod-
uct seized by the investigators was a shiny, white, 
fine-grained powder containing methylone, with a 
degree of purity of 83.3%18. 
A severe hyperthermia (41.2°C) with hyperten-
sion, increased muscle tonus and sialorrhea was 
noted in a 21 years old male admitted at Intensive 
Care of the Hospital in Nowy Targ (Poland) in 2012 
following the suicidal ingestion of 10 tablets of an 
internet-sold bath salt: ‘‘Amph-i-bia’’. The man died 
after repeated cardiac arrests with asystole. Buty-
lone (bk-MBDB) was identified and quantified at 
concentrations of 20 mg/L in the blood and 33 mg/
kg in the liver samples for the deceased. This case 
report was a further confirmation of the serotonine 
toxidrome triggered by a synthetic cathinone19.
A capsule containing both 422 mg methylone 
and 53 mg buthylone was the cause of multi-sys-
tem organ failure and consequent death in a 
healthy 24-year-old girl who ingested the capsule 
sold as “ecstasy” at a concert. The patient present-
ed to the Emergency Department with a classical 
serotonin syndrome (comatose febrile, tachycar-
dic, tachypnic, and hypertensive status). Labora-
tory analysis identified only methylone and buty-
lone in girl urine, but did not quantify them20.
Fatalities following the ingestion of synthet-
ic cathinones occurred also in Japan, as shown in 
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substances is still scarce and spreads in different 
parts of the world. It should be emphasized that 
the disclosure of synthetic cathinones-related 
fatalities real figures can be hindered by sever-
al factors, including lack of specific analytical 
methods for biological samples, and consumed 
product testing, polydrug use. In this latter 
concern, these products sold as ‘‘bath salt’’ or 
‘‘plant feeders’’, etc. could also contain other 
NPD, such as synthetic cannabinoids or pipera-
zines. Indeed, in most intoxication cases where 
biological samples have been analyzed other 
psychoactive substances and/or their metabo-
lites have been detected. It is likely that some 
of these substances are consumed to counteract 
the unwanted effects of cathinones, for exam-
ple benzodiazepines to reduce anxiety, panic 
attacks, or insomnia. Conversely, others can re-
sult in synergic effects such as cocaine, amphet-
amine-type substances or selective serotonin 
reuptake inhibitors antidepressants with a pos-
sible increased sympathomimetic toxicity up to 
serotonin toxydrome. Finally, natural but most 
importantly synthetic cannabinoids can increase 
hallucinations25. 
The new psychoactive substances market 
alongside the “legal highs” or bath salts, which 
are the most sold and consumed, has reached new 
groups of consumers with the alleged promises 
of new and prolonged sensations26. Among them, 
also the hypothesized possibility to facilitate and/
or to enhance sexual intercourses when using 
psychostimulant drugs, including synthetic cathi-
nones mostly among men who have sex with other 
men in a context recently defined as “chemsex”27.
The reality is that both effective and toxic dos-
es of these substances are unknowns; systematic 
clinical studies on both animal and human model 
are lacking and users are the sole experimenters 
with possible hazardous consequences 28.
Conclusions
In reviewing and showing data regarding syn-
thetic cathinones related fatalities, we wish to 
draw the attention of the whole scientific commu-
nity on the importance of improving surveillance 
and data sharing through national and internatio-
nal early warning systems and a standardization 
in reporting related deaths. Analytical methodo-
logies for the identification of parent compounds 
and eventual metabolites both in ante-mortem and 
post-mortem cases should be developed, valida-
ted, and analytical data shared through different 
communication platforms with the aim o contain 
this serious threat for the health of drug users.
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